Category: DMT

  • Can psychedelics provide breakthrough in mental health?

    There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. Ben Hargreaves discovers why medical research in the area has shifted from being highly controversial to being backed by major pharma companies and venture capital. […]

  • Small Pharma stock market launch funds DMT-based depression drug trial

    UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 63 million Canadian dollars (around £37m) to develop medicines based on dimethyltriptylene (DMT) to treat depression. Small Pharma is following the trend for development of psychedelic medicines, a field where research has been suppressed for years because of legal restrictions on use of […]